Radiation oncologists at Rush University Medical Center are intent on finding ways to avoid damage to the critically important hippocampus and limbic circuit of the brain when cranial radiation is required to treat existing or potential metastatic cancers.

Original post: 
Avoiding Damage To Neurocognitive Areas Of The Brain During Cranial Radiation

Related posts:

1. Polymer Therapeutic Protects Gut From Radiation Damage, Infection After Cancer TreatmentA non-absorbed, oral co-polymer therapy under development by Midway Pharmaceuticals demonstrated the ability to protect against damage to healthy gastrointestinal tissues and to prevent lethal bacterial infections in animal models...
2. Discovery Makes Brain Tumor Cells More Responsive To RadiationDuke University Medical Center researchers have figured out how stem cells in the malignant brain cancer glioma may be better able to resist radiation therapy. And using a drug to...
3. Childhood Lead Exposure Causes Permanent Brain DamageA study using functional magnetic resonance imaging (fMRI) to evaluate brain function revealed that adults who were exposed to lead as children incur permanent brain injury. The results were presented...
4. In Non-Small Cell Lung Cancer PET Imaging Before Radiation Not Ideal For Determining Boost Radiation DosesPositron emission tomography (PET) imaging of non-small cell lung cancer prior to receiving radiation therapy should not be the basis for determining areas that may benefit from higher doses of...
5. Cancer Recurrence May Be Prevented By Chemo-Radiation Before Prostate RemovalResearchers in the Oregon Health & Science University Knight Cancer Institute and the Portland Veterans Affairs Medical Center have found a combination of radiation therapy and chemotherapy given before prostate...
6. Cancer Recurrence May Be Prevented By Chemo-Radiation Before Prostate RemovalResearchers in the Oregon Health & Science University Knight Cancer Institute and the Portland Veterans Affairs Medical Center have found a combination of radiation therapy and chemotherapy given before prostate...
7. Johnson & Johnson Focused Funding Award Goes To Breakthrough Research Of Brain Cell Damage In Parkinson’s DiseaseDr. Sarit Larisch, Head of the Cell Death Research Laboratory and senior lecturer at the University of Haifa, has been awarded the prestigious Johnson & Johnson Focused Funding grant for...
8. Three-week Course Of Breast Radiation May Be As Effective As Conventional Five To Seven Week Course For Early Breast CancersAccording to a study presented November 4, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO), a shortened, more intensive course of radiation given to...
9. FDA Probes Excessive Radiation Dose CasesThe Associated Press/Wall Street Journal: "Federal health regulators are investigating reports of dangerous radiation levels at two more California hospitals, following earlier unsafe medical scans at a Los Angeles facility....
10. How is Cranial Release Technique Changing Chiropractic Care?In a recent interview with Dr. William Doreste (DC) on Chiropractic Corner he spoke about Cranial Release Technique (CRT) as a natural, hands-on approach to releasing the body's inborn capacity...
11. BJOG Release: Study Finds Higher Incidence Of Gynaecological Cancers In Urban AreasNew research to be published in BJOG: An International Journal of Obstetrics and Gynaecology has found a higher incidence of gynaecological cancers (uterine, ovarian and cervical cancer) in urban areas...
12. Human Mdm2: A New Molecular Link To Late-stage Metastatic Breast CancerA large proportion of late-stage breast cancers that have spread to other parts of the body (metastatic breast cancers) are characterized by overexpression of the protein Mdm2. Lindsey Mayo and...
13. FDA Makes Interim Recommendations To Address Concern Of Excess Radiation Exposure During CT Perfusion ImagingAs part of an ongoing investigation into cases of excess radiation during CT perfusion imaging of the brain, the U.S. Food and Drug Administration provided imaging facilities and practitioners with...
14. It’s Safe To Treat HER2-Positive Breast Cancer With Trastuzumab And Adjuvant Radiation, Study FindsStandard adjuvant treatment for HER2-positive breast cancer patients, following primary surgery for their cancer, is Trastuzumab (Herceptin) - typically used in combination with chemotherapy. However, a new study by researchers...
15. Racial Disparities Exist In Radiation Therapy Rates For Early Stage Breast CancerBlack women are less likely than white women to receive radiation therapy after a lumpectomy, the standard of care for early stage breast cancer, according to a new study by...